InsidersTradesSigma
Follow the Defence Therapeutics Inc. share price and the full insider trade history of the company, a listed equity based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €38.7m. The latest transaction was disclosed on 6 August 2026 (50 - Grant of options). Among the most active insiders: Beaver, John David. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Defence Therapeutics Inc. es una empresa centrada en el desarrollo de terapias innovadoras para el tratamiento del cáncer y otras enfermedades. Cotiza en la Bolsa de Valores de Toronto bajo el símbolo XTSE.